×
Program Committee
-
Nancy A Dreyer, PHD, MPH, FISPE Founder
Dreyer Strategies LLC, United States -
Steven A. Anderson, PHD Director, Office of Biostatistics and Epidemiology, CBER
FDA, United States -
Dorothee Bartels, PHD, MSC Chief Digital Officer
Aetion, Germany -
Brian Bradbury, DRSC, MA Vice President, Center for Observational Research
Amgen, United States -
Paul M. Coplan, DRSC, MBA, MSC, FISPE VP, Medical Device Epidemiology & Real-World Data Analytics
Johnson & Johnson, United States -
Marni Hall, PHD, MPH Vice President and General Manager, Global Regulatory Science and Strategy
IQVIA, United States -
James Harnett, PHARMD, MS Executive Director, Health Economics and Outcomes Research
Regeneron Pharmaceuticals, Inc. , United States -
Jingyu (Julia) Luan, PHD Executive Regulatory Science Director, BioPharmaceuticals R&D
AstraZeneca, United States -
David Martin, MD, MPH Vice President, Head, PCO Center of Excellence
Novartis, United States -
Robert Reynolds, DRSC, MSC, FISPE Vice President, Global Epidemiology, CMO, R&D
GSK, United States -
Debra Schaumberg, DRSC, MPH Vice President and Global Head, Startegic Development Consulting Chair
Evidera | PPD, United States -
Mark Stewart, PHD Vice President, Science Policy
Friends of Cancer Research, United States
Have an account?